Cutler Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-155
| Closed | -$1K | – | 2417 |
|
|
2020
Q2 | $1K | Hold |
155
| – | – | ﹤0.01% | 1483 |
|
|
2020
Q1 | $0 | Sell |
155
-185
| -54% | – | ﹤0.01% | 2229 |
|
|
2019
Q4 | $4K | Hold |
340
| – | – | ﹤0.01% | 1347 |
|
|
2019
Q3 | $3K | Hold |
340
| – | – | ﹤0.01% | 1348 |
|
|
2019
Q2 | $5K | Hold |
340
| – | – | ﹤0.01% | 1388 |
|
|
2019
Q1 | $11K | Hold |
340
| – | – | ﹤0.01% | 1185 |
|
|
2018
Q4 | $9K | Hold |
340
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q3 | $20K | Hold |
340
| – | – | ﹤0.01% | 1172 |
|
|
2018
Q2 | $25K | Hold |
340
| – | – | ﹤0.01% | 1080 |
|
|
2018
Q1 | $22K | Sell |
340
-498
| -59% | -$32.2K | ﹤0.01% | 1175 |
|
|
2017
Q4 | $70K | Buy |
838
+76
| +10% | +$6.35K | ﹤0.01% | 980 |
|
|
2017
Q3 | $87K | Buy |
762
+614
| +415% | +$70.1K | ﹤0.01% | 1053 |
|
|
2017
Q2 | $17K | Sell |
148
-1,432
| -91% | -$164K | ﹤0.01% | 1938 |
|
|
2017
Q1 | $194K | Buy |
1,580
+1,540
| +3,850% | +$189K | 0.01% | 849 |
|
|
2016
Q4 | $5K | Sell |
40
-290
| -88% | -$36.3K | ﹤0.01% | 2503 |
|
|
2016
Q3 | $65K | Sell |
330
-328
| -50% | -$64.6K | ﹤0.01% | 1303 |
|
|
2016
Q2 | $85K | Sell |
658
-1,004
| -60% | -$130K | ﹤0.01% | 1098 |
|
|
2016
Q1 | $155K | Sell |
1,662
-180
| -10% | -$16.8K | 0.01% | 713 |
|
|
2015
Q4 | $373K | Buy |
+1,842
| New | +$373K | 0.02% | 475 |
|